Shandong International Biotechnology Park. Our Superiority. Beijing. 环渤海经济圈. Dalian. Bohai Rim. Tokyo. Seoul. Yantai. Qingdao. Osaka. Shanghai. 长江三角洲经济圈. Yangtze River Delta Rim. Shenzhen. 珠江三角洲经济圈. Pearl River Delta Rim. Our Superiority.
Shandong International Biotechnology Park
Yangtze River Delta Rim
Pearl River Delta Rim
Figure 1. The 31 province 2010 GDP and growth in China
Shandong is the forefront in the field of biomedicine and marine life in China .
Shandong is the largest province in pharmaceutical industry, and the sales income is No. 1 .
(data from：National Development and Reform Commission)
Why choose Yantai ？
Why build a nation-class biotechnology park in Yantai？
“UN Habitat Scroll of Honor Award”
“Chinese Top Habitat Award”
“Chinese City with the Best Investment Environment”
“Top Chinese Tourist City”
“National Model City in Environmental Protection”
“Chinese City with Top Innovation Environment”
“Chinese City with Top Innovation Power”
“Chinese City with Top Innovation Achievements”
Yantai is rich in biological resources, and in the biological industry, there has formed a certain scale and characteristics with a number of innovative companies with core competitiveness.
Shandong Province 2011 GDP ranking:Qingdao: 104 billion USDYantai: 77 billion USDJinan: 69 billion USD
(data from：Shandong Development and Reform Commission)
Total Area：1.37 hectaresThe general population：6,470,000
Yantai High-Tech Zone:
Total Area:48.8 square km.
3 kilometers far away from Yantai Government.
Nearby Universities and Research Institutes
Binzhou Medical College
Ocean University of China
China Agricultural University (Yantai)
Shandong Institute of Business and Technology
Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences
Naval Aeronautical Engineering Institute
6 km away from Yantai Laishan International Airport;
15 km away from Yantai Port;
200 km away from Qingdao Port;
89 sea miles away from Dalian Port
Inter-city express railway
1046 acres, total area of the park;
566 acres, research and development area; 480 acres, supporting area;
560,000 square meters designed R & D area ;
510,000 square meters supporting area .
Focused on R&D in four main areas：
Bio-pharma:gene therapy, antibody drug, targeted therapeutics, stem cell therapy, translational medicine, personalized therapy, modern traditional Chinese medicine, diagnostic reagents, medical devices, etc..Marine Biology:marine pharmaceuticals, oceanic functional food and cosmetics, novel marine biomaterial, marine bio-enzyme, etc..Biological Agriculture:transgenic breeding, animal vaccine, bio-pesticide, bio-feeds, plant growth regulator, etc..
Health care: The international medical rehabilitation center, Cosmetic Medicine, Care training center, etc..
We can offered
Progress－20 Enterprise enterred
Currently the starting building has been completed and put into use, and the 2nd phase, total area of 120,000 square meters R&D Incubator, has been fully built.
Has attracted more than 20 projects, more than half of which were founded by the outstanding returnees talent, introduced 15 high-level personnel with doctoral degrees, 12 of them having overseas study background.
Platform of long-term sustained release microsphere
Relying on the ”State Key Laboratory of long-term and targeted agents”, the research is in the international and domestic leading position. 8 projects with independent intellectual property rights, 3 research enter the clinical phase, in which two has entered in U.S. FDA declaration.
Development platform of holistic monoclonal antibody drug
Relying on the biotechnology center in the park, (co-found with Singapore A-bio biotechnology company), committed to the human monoclonal antibody drug development.
R&D platform of Marine active material
Base on the marine biotechnology center (co-build with Chinese Academy of Sciences Institute of Oceanology, Institute of coastal zone research), committed to the development of marine pharmaceuticals and other high value products.
Shandong international biotech park has been included into the comprehensive national drug research and development technology platform, an important part of ”Shandong Key New Drug Creation Center ", a national innovative drugs (Yantai) incubation base.
Events—Foundation Stone Laying Ceremony
The foundation stone laying ceremony of Shandong International Biotechnology Park was held on August 6, 2010. There were more than 700 attendees, as well as more than 10 National Academy Members and industry leaders.
Jia Qinglin, Chairman of the CPPCC National Committee, visit Shandong
International Biotechnology Park to guide the work during his investigation
Big Event－ Leading Care
November 6, 2011, Sang Guowei, vice chairman of the NPC Standing Committee, director of Chinese Pharmaceutical Association, and his entourage had a visit to Shandong international biotech park.
Big Event－ Leading Care
Director of MST torch center Zhao Mingpeng’s, visit,
MST vice Minister Cao Jianlin visit
State Food and Drug Supervision Bureau, deputy director Bian Zhenjia’s visit
Ding Jian, academician, from Shanhai institute of Materia Medica visit
After 10 years, to the year of 2020：
Settled more than 100 R&D centers from the famous enterprises; settled more than 100 R&D centers / laboratories from domestic and foreign well-known research institutes; settled more than 300 biotechnology companies.
Have more than 10 internationally renowned brand products, more than 100 listed products with independent intellectual property and 200 of the leading international scientific and technological achievements, the international and domestic patent applications will reach 5000;
Attract 10 renowned scientists in the field of international biotechnology; 20 domestic famous scientist in the field of biotechnology; 200 academic leaders;
Over one million permanent staff will locate in the park
Tenet and Goal
Good Faith Professionalism Innovation
Innovative Research，Happy Life